COMPASS Pathways CMPS Stock
8.66 USD
{{ price }}
-5.664493%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Medical Care Facilities
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
591.85M USD
LOW - HIGH [24H]
8.6
-
9.22 USD
VOLUME [24H]
465.9K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.32 USD
COMPASS Pathways Price Chart
COMPASS Pathways CMPS Financial and Trading Overview
| COMPASS Pathways stock price | 8.66 USD |
| Previous Close | 7.88 USD |
| Open | 7.83 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 7.72 - 8.05 USD |
| 52 Week Range | 6.97 - 21.5 USD |
| Volume | 144.02K USD |
| Avg. Volume | 259.46K USD |
| Market Cap | 367.25M USD |
| Beta (5Y Monthly) | 2.500563 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.3 USD |
CMPS Valuation Measures
| Enterprise Value | 251.68M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.1818182 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.1301932 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.501 |
Trading Information
COMPASS Pathways Stock Price History
| Beta (5Y Monthly) | 2.500563 |
| 52-Week Change | -18.93% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.5 USD |
| 52 Week Low | 6.97 USD |
| 50-Day Moving Average | 8.51 USD |
| 200-Day Moving Average | 9.85 USD |
CMPS Share Statistics
| Avg. Volume (3 month) | 259.46K USD |
| Avg. Daily Volume (10-Days) | 185.13K USD |
| Shares Outstanding | 45.62M |
| Float | 16.23M |
| Short Ratio | 13.15 |
| % Held by Insiders | 45.42% |
| % Held by Institutions | 20.82% |
| Shares Short | 2.51M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 5.51% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -28.33% |
| Return on Equity (ttm) | -44.88% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -100629000 USD |
| Net Income Avi to Common (ttm) | -94542000 USD |
| Diluted EPS (ttm) | -2.23 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 117.1M USD |
| Total Cash Per Share (mrq) | 2.57 USD |
| Total Debt (mrq) | 1.52M USD |
| Total Debt/Equity (mrq) | 0.94 USD |
| Current Ratio (mrq) | 14.913 |
| Book Value Per Share (mrq) | 3.779 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -110051000 USD |
| Levered Free Cash Flow (ttm) | -76495624 USD |
Profile of COMPASS Pathways
| Country | United States |
| State | N/A |
| City | London |
| Address | 33 Broadwick Street |
| ZIP | W1F 0DQ |
| Phone | 44 71 6676 6461 |
| Website | https://compasspathways.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 181 |
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Q&A For COMPASS Pathways Stock
What is a current CMPS stock price?
COMPASS Pathways CMPS stock price today per share is 8.66 USD.
How to purchase COMPASS Pathways stock?
You can buy CMPS shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for COMPASS Pathways?
The stock symbol or ticker of COMPASS Pathways is CMPS.
Which industry does the COMPASS Pathways company belong to?
The COMPASS Pathways industry is Medical Care Facilities.
How many shares does COMPASS Pathways have in circulation?
The max supply of COMPASS Pathways shares is 68.34M.
What is COMPASS Pathways Price to Earnings Ratio (PE Ratio)?
COMPASS Pathways PE Ratio is now.
What was COMPASS Pathways earnings per share over the trailing 12 months (TTM)?
COMPASS Pathways EPS is -2.32 USD over the trailing 12 months.
Which sector does the COMPASS Pathways company belong to?
The COMPASS Pathways sector is Healthcare.
COMPASS Pathways CMPS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}